Clinical Trials Logo

Filter by:
NCT ID: NCT01554475 Completed - Dementia Clinical Trials

Use of Alternative Medicine in Patients With Dementia and Mild Cognitive Dysfunction

Start date: March 2012
Phase: N/A
Study type: Observational

So far, no drugs have shown to stop or delay the pathological processes of dementia. Available pharmacological treatment includes a small number of drugs; cholinesterase inhibitors like donepezil, galantamine and rivastigmine, and the NMDA receptor antagonist memantine, all of which only affect the symptoms of the disease. At the same time, alternative medicines like herbal products and dietary supplements are often intensively marketed with the assertion of curative or alleviating effects on dementia. The documentation of clinical effects, side effects and the potential for interaction with prescribed drugs are, however, generally scarce. The aims of this study are to make a survey of the use of alternative medicine in patients with dementia and mild cognitive dysfunction attending the investigators out-patient dementia clinic, and to assess the interaction potential with the patient's other medications.

NCT ID: NCT01552993 Recruiting - Infant, Premature Clinical Trials

Registration and Treatment of Pain During Eye Examination of Prematurity

Start date: March 2012
Phase: N/A
Study type: Interventional

The aim of this study is to see if paracetamol has a pain-relieving effect during eye examination in premature infants.

NCT ID: NCT01552135 Completed - Healthy Skin Clinical Trials

Pilot Study - Putative Penetration of Nanoparticles in Sunscreen in Intact or Sunburned Skin

Start date: January 2012
Phase:
Study type: Observational

The investigators want to study if nanoparticles of titaniumdioxide are penetrating skin when the skin is intact and when the skin is sunburned. The hypothesis is "Does nanotitandioxide penetrate intact or sunburned skin?"

NCT ID: NCT01552018 Completed - Clinical trials for Coronary Artery Disease

Saxagliptin and Atherosclerosis

SAXATH
Start date: March 2012
Phase: Phase 4
Study type: Interventional

Dipeptidyl peptidase 4 (DPP-4) inhibitors are approved as add on therapy to improve glycaemic control in Type 2 Diabetes Mellitus (T2DM). DPP-4 inactivates the incretin hormone glucagon-like peptide 1 (GLP-1). Inhibiting the inactivation of GLP-1 leads to increased insulin- and reduced glucagon secretion after meals. DPP-4 has been shown to be present in atherosclerotic plaques. DPP-4 is a protease with substrates including cytokines and chemokines associated with atherosclerosis/inflammation. The purpose of this study is to explore the effects of 3 months intervention with DPP-4 inhibitor saxagliptin on biomarkers related to atherosclerosis in patients with stable coronary artery disease (CAD) and T2DM, on circulating levels and on expression levels in circulating monocytes and adipose tissue. A reduction in markers associated with atherosclerosis could indicate an antiatherosclerotic effect of DPP-4 inhibitors beyond glycaemic control alone. Due to reduced sample size (recruitment problems) the main focus has changed and will now be on cellular aspects and gene regulation (initially secondary outcome measure).

NCT ID: NCT01551563 Recruiting - IBD Clinical Trials

Stavanger University Hospital Inflammatory Bowel Disease Trial

SUSI
Start date: April 2012
Phase:
Study type: Observational

The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined. Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.

NCT ID: NCT01551134 Terminated - Clinical trials for Gastroesophageal Reflux

Is Laparoscopic Fundoplication Better Than Open Fundoplication in Children ?

Start date: January 2003
Phase: N/A
Study type: Interventional

The aim of the study was to compare short- and longterm outcomes after laparoscopic and open Nissen fundoplication in children.

NCT ID: NCT01550237 Active, not recruiting - Prostatic Neoplasms Clinical Trials

Curative Image Guided Radiotherapy for Prostate Cancer

RIC
Start date: October 2012
Phase: N/A
Study type: Interventional

The clinical importance of cone beam computer tomography based image guided radiotherapy (CT- IGRT) has not been established. The primary aim of the present trial is to investigate whether CT- IGRT and consequently reduced safety margins reduces the rectal side effects from curative, high dose radiotherapy in prostate cancer. Any impact of the reduced planning target volume in the CT- IGRT arm on biochemical freedom from disease will be evaluated as secondary outcome. An open randomised phase III trial. The included men will be randomised to receive curative radiotherapy to 78 Gy in 39 fractions with weekly orthogonal position verification and standard safety margins (10-15 mm) or 78 Gy in 39 fractions with daily CT position verification and reduced safety margins (7mm).

NCT ID: NCT01550081 Completed - Clinical trials for Coronary Artery Disease

Target Heart Rate and Aerobic Interval Training

Start date: March 2012
Phase: N/A
Study type: Interventional

Aerobic interval training is shown to be superior in increasing oxygen uptake in both healthy and patients with coronary artery disease (CAD), compared to moderate continuous training. However, in cardiac rehabilitation exercise groups, exercise intensity is usually controlled with perceived exertion (Borg scale). The investigators will investigate degree of agreement between target heart rate and perceived exertion during interval training in cardiac rehabilitation.

NCT ID: NCT01546467 Recruiting - Schizophrenia Clinical Trials

Cognitive Remediation in Early Phase Psychosis

Start date: September 2009
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate the effect of a 30 hour cognitive remediation program for young patients with early phase schizophrenia spectrum disorders on cognitive, clinical and functional outcome measures. The remediation program is integrated with whatever active rehabilitation the participant is currently attending (school, work, day program etc).

NCT ID: NCT01544491 Completed - Clinical trials for Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

Start date: August 17, 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if everolimus combined with reduced exposure CNI (TAC) is efficacious and safe and will support corticosteroid elimination compared to a standard exposure CNI (TAC) + MMF + steroid regimen after paediatric kidney transplantation. An additional purpose of the study is to assess the effect of the combination of EVR and reduced exposure CNI (TAC) on renal function. This study is part of the requirements of the Paediatric Investigational Plan approved by Paediatric Committee at the European Medicines Agency (PDCO/EMA) on September 10, 2010, and is intended to support the indication of everolimus in the prevention of acute rejection in paediatric recipients of a renal transplant.